Maspin suppresses growth, proliferation and invasion in cutaneous squamous cell carcinoma cells

Zhu,Hong; Mao,Qing; Liu,Weiwei; Yang,Zhenhai; Jian,Xiaoqing; Qu,Le; He,Chundi

doi:10.3892/or.2017.5574

Maspin suppresses growth, proliferation and invasion in cutaneous squamous cell carcinoma cells

Authors:
- Hong Zhu
- Qing Mao
- Weiwei Liu
- Zhenhai Yang
- Xiaoqing Jian
- Le Qu
- Chundi He
View Affiliations

Affiliations: Department of Dermatology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China, Department of Dermatology, Chengdu Fifth People's Hospital, Chengdu, Sichuan 611130, P.R. China, Department of Dermatology, Chaoyang Second Hospital, Chaoyang, Liaoning 122000, P.R. China
Published online on: April 11, 2017 https://doi.org/10.3892/or.2017.5574
Pages: 2875-2882

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cutaneous squamous cell carcinoma (cSCC) is a common malignant tumor. Mammary serine protease inhibitor (Maspin), a member of serpin family, has been reported as a tumor suppressor in various carcinomas. In this study, we detected the expression level of Maspin in cSCC tissues by real-time PCR and western blotting, and found that Maspin was downregulated in the cSCC tissues compared with the adjacent normal tissues. Moreover, Maspin was stably overexpressed in A431 cells, and CCK-8 assay, colony formation assay, Transwell assay, Hoechst staining and western blotting were carried out to detect the growth, proliferation, invasion, cell cycle and apoptosis of A431 cells. The results revealed that overexpression of Maspin inhibited growth, proliferation, invasion and cell cycle G1/S/G2 transition and enhanced apoptosis of A431 cells. The pro-apoptotic protein cleaved caspase-3, poly(ADP-ribose) polymerase (PARP) and Bax increased, and the anti-apoptotic protein Bcl-2 decreased after Maspin overexpression. Therefore, we demonstrated that Maspin suppressed growth, proliferation and invasion by delaying cell cycle transition and promoting apoptosis in cSCC cells, which may provide new insights for the clinical diagnosis and therapy of cSCC.

View Figures

View References

1	Lohmann CM and Solomon AR: Clinicopathologic variants of cutaneous squamous cell carcinoma. Adv Anat Pathol. 8:27–36. 2001. View Article : Google Scholar : PubMed/NCBI
2	Alam M and Ratner D: Cutaneous squamous-cell carcinoma. N Engl J Med. 344:975–983. 2001. View Article : Google Scholar : PubMed/NCBI
3	Bonerandi JJ, Beauvillain C, Caquant L, Chassagne JF, Chaussade V, Clavère P, Desouches C, Garnier F, Grolleau JL, Grossin M, et al: French Dermatology Recommendations Association (aRED): Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. J Eur Acad Dermatol Venereol. 25:(Suppl 5). 1–51. 2011. View Article : Google Scholar : PubMed/NCBI
4	Aboutalebi S and Strickland FM: Immune protection, natural products, and skin cancer: Is there anything new under the sun? J Drugs Dermatol. 5:512–517. 2006.PubMed/NCBI
5	Weinberg AS, Ogle CA and Shim EK: Metastatic cutaneous squamous cell carcinoma: An update. Dermatol Surg. 33:885–899. 2007. View Article : Google Scholar : PubMed/NCBI
6	Lippman SM, Parkinson DR, Itri LM, Weber RS, Schantz SP, Ota DM, Schusterman MA, Krakoff IH, Gutterman JU and Hong WK: 13-cis-retinoic acid and interferon alpha-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst. 84:235–241. 1992. View Article : Google Scholar : PubMed/NCBI
7	Kwa RE, Campana K and Moy RL: Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 26:1–26. 1992. View Article : Google Scholar : PubMed/NCBI
8	Tanvetyanon T, Padhya T, McCaffrey J, Kish JA, Deconti RC, Trotti A and Rao NG: Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck. Head Neck. 37:840–845. 2015. View Article : Google Scholar : PubMed/NCBI
9	El-Maqsoud Abd NM and Tawfiek ER: Loss of Maspin expression in bladder cancer: Its relationship with p53 and clinicopathological parameters. J Egypt Natl Canc Inst. 22:1–12. 2010.PubMed/NCBI
10	Hopkins PC and Whisstock J: Function of maspin. Science. 265:1893–1894. 1994. View Article : Google Scholar : PubMed/NCBI
11	Pemberton PA, Wong DT, Gibson HL, Kiefer MC, Fitzpatrick PA, Sager R and Barr PJ: The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin. J Biol Chem. 270:15832–15837. 1995. View Article : Google Scholar : PubMed/NCBI
12	Al-Ayyoubi M, Gettins PG and Volz K: Crystal structure of human maspin, a serpin with antitumor properties: Reactive center loop of maspin is exposed but constrained. J Biol Chem. 279:55540–55544. 2004. View Article : Google Scholar : PubMed/NCBI
13	Bodenstine TM, Seftor RE, Khalkhali-Ellis Z, Seftor EA, Pemberton PA and Hendrix MJ: Maspin: Molecular mechanisms and therapeutic implications. Cancer Metastasis Rev. 31:529–551. 2012. View Article : Google Scholar : PubMed/NCBI
14	Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E and Sager R: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science. 263:526–529. 1994. View Article : Google Scholar : PubMed/NCBI
15	Cai Z, Zhou Y, Lei T, Chiu JF and He QY: Mammary serine protease inhibitor inhibits epithelial growth factor-induced epithelial-mesenchymal transition of esophageal carcinoma cells. Cancer. 115:36–48. 2009. View Article : Google Scholar : PubMed/NCBI
16	Wu S, Yu L, Cheng Z, Song W, Zhou L and Tao Y: Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry. J Huazhong Univ Sci Technolog Med Sci. 32:346–352. 2012. View Article : Google Scholar : PubMed/NCBI
17	Zhang W, Shi HY and Zhang M: Maspin overexpression modulates tumor cell apoptosis through the regulation of Bcl-2 family proteins. BMC Cancer. 5:502005. View Article : Google Scholar : PubMed/NCBI
18	Li X, Chen D, Yin S, Meng Y, Yang H, Landis-Piwowar KR, Li Y, Sarkar FH, Reddy GP, Dou QP, et al: Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells. J Cell Physiol. 212:298–306. 2007. View Article : Google Scholar : PubMed/NCBI
19	Dzinic SH, Chen K, Thakur A, Kaplun A, Bonfil RD, Li X, Liu J, Bernardo MM, Saliganan A, Back JB, et al: Maspin expression in prostate tumor elicits host anti-tumor immunity. Oncotarget. 5:11225–11236. 2014. View Article : Google Scholar : PubMed/NCBI
20	Reis-Filho JS, Torio B, Albergaria A and Schmitt FC: Maspin expression in normal skin and usual cutaneous carcinomas. Virchows Arch. 441:551–558. 2002. View Article : Google Scholar : PubMed/NCBI
21	Abdou AG, Maraee AH, El-Monaem Shoeib MA and Abo Saida AM: Maspin expression in epithelial skin tumours: An immunohistochemical study. J Cutan Aesthet Surg. 4:111–117. 2011. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Wang JH, Zhang L, Ma YW, Xiao J, Zhang Y, Liu M and Tang H: microRNA-34a-upregulated retinoic acid-inducible gene-I promotes apoptosis and delays cell cycle transition in cervical cancer cells. DNA Cell Biol. 35:267–279. 2016. View Article : Google Scholar : PubMed/NCBI
24	Cassarino DS, Derienzo DP and Barr RJ: Cutaneous squamous cell carcinoma: A comprehensive clinicopathologic classification. Part one. J Cutan Pathol. 33:191–206. 2006. View Article : Google Scholar : PubMed/NCBI
25	Cassarino DS, Derienzo DP and Barr RJ: Cutaneous squamous cell carcinoma: A comprehensive clinicopathologic classification - part two. J Cutan Pathol. 33:261–279. 2006. View Article : Google Scholar : PubMed/NCBI
26	Demchenko AP: The change of cellular membranes on apoptosis: Fluorescence detection. Exp Oncol. 34:263–268. 2012.PubMed/NCBI
27	Bounda GA, Zhou W, Wang DD and Yu F: Rhein elicits in vitro cytotoxicity in primary human liver HL-7702 cells by inducing apoptosis through mitochondria-mediated pathway. Evid Based Complement Alternat Med. 2015:3298312015. View Article : Google Scholar : PubMed/NCBI
28	Nicholson DW and Thornberry NA: Caspases: Killer proteases. Trends Biochem Sci. 22:299–306. 1997. View Article : Google Scholar : PubMed/NCBI
29	Yi CH and Yuan J: The Jekyll and Hyde functions of caspases. Dev Cell. 16:21–34. 2009. View Article : Google Scholar : PubMed/NCBI
30	Sarvothaman S, Undi RB, Pasupuleti SR, Gutti U and Gutti RK: Apoptosis: Role in myeloid cell development. Blood Res. 50:73–79. 2015. View Article : Google Scholar : PubMed/NCBI
31	Snigdha S, Smith ED, Prieto GA and Cotman CW: Caspase-3 activation as a bifurcation point between plasticity and cell death. Neurosci Bull. 28:14–24. 2012. View Article : Google Scholar : PubMed/NCBI
32	Gerö D and Szabó C: Poly(ADP-ribose) polymerase: A new therapeutic target? Curr Opin Anaesthesiol. 21:111–121. 2008. View Article : Google Scholar : PubMed/NCBI
33	Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ: Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science. 292:727–730. 2001. View Article : Google Scholar : PubMed/NCBI
34	Besbes S, Mirshahi M, Pocard M and Billard C: New dimension in therapeutic targeting of BCL-2 family proteins. Oncotarget. 6:12862–12871. 2015. View Article : Google Scholar : PubMed/NCBI
35	Danial NN and Korsmeyer SJ: Cell death: Critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
36	Nagata Y, Nagahisa H, Aida Y, Okutomi K, Nagasawa T and Todokoro K: Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells. J Biol Chem. 270:19673–19675. 1995. View Article : Google Scholar : PubMed/NCBI
37	Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E and Srivastava S: p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem. 275:6051–6054. 2000. View Article : Google Scholar : PubMed/NCBI
38	Eitel JA, Bijangi-Vishehsaraei K, Saadatzadeh MR, Bhavsar JR, Murphy MP, Pollok KE and Mayo LD: PTEN and p53 are required for hypoxia induced expression of maspin in glioblastoma cells. Cell Cycle. 8:896–901. 2009. View Article : Google Scholar : PubMed/NCBI
39	Chen WS, Yen CJ, Chen YJ, Chen JY, Wang LY, Chiu SJ, Shih WL, Ho CY, Wei TT, Pan HL, et al: miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin. Oncotarget. 6:25962–25974. 2015. View Article : Google Scholar : PubMed/NCBI
40	Yuan K, Xie K, Fox J, Zeng H, Gao H, Huang C and Wu M: Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice. Gastroenterology. 145:853–864, e859. 2013. View Article : Google Scholar : PubMed/NCBI